Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

NovaBay unveils advanced wound care product

NovaBay Pharmaceuticals, a developer of patented Aganocide compounds, has unveiled its NeutroPhase.

NeutroPhase consists of pure, isotonic stable hypochlorous acid solution to treat chronic non-healing wounds, such as pressure, venous stasis and diabetic ulcers.

Hypochlorous acid is an anti-biofilm, broad-spectrum, antimicrobial agent which is similar to agent produced by white blood cells to defend against bacteria and is safe, well-tolerated in human tissues.

NeutroPhase is packaged in a convenient glass container which will insure its long-term shelf stability.

NeutroPhase has received two 510(k) clearances from the US Food and Drug Administration (FDA) as a wound cleanser.